Tirzepatide shots are weekly GIP/GLP-1 injections for type 2 diabetes and weight loss. Learn dosing, side effects, cost, and how to inject safely.
Tirzepatide shots are once-weekly injections of a dual GIP and GLP-1 receptor agonist prescribed for type 2 diabetes and chronic weight management. In the United States, tirzepatide is sold as Mounjaro for diabetes and Zepbound for weight loss, and both brands are FDA-approved. Tirzepatide is a prescription medication rather than a cure, and it works best alongside nutrition and activity changes.
What Are Tirzepatide Shots?
Tirzepatide is a synthetic peptide that mimics two hormones your gut releases after you eat. A single tirzepatide shot is given under the skin, usually once every seven days. A tirzepatide inj is not a daily medication, which is one reason many people find the routine manageable.
Two brand-name products dominate the US market:
- Mounjaro — FDA-approved for type 2 diabetes, sometimes prescribed off-label for weight loss.
- Zepbound — FDA-approved for chronic weight management in adults with obesity, or with overweight plus at least one weight-related condition.
Compounded versions circulated widely during the 2022–2024 shortage. The FDA has since declared the tirzepatide shortage resolved, which sharply limits when a compounding pharmacy may legally produce it.
How Tirzepatide Injections Work
GLP-1 slows stomach emptying and signals fullness to the brain. GIP adds a second pathway that appears to influence how the body handles fat and glucose. Together, the two hormones reduce appetite and calorie intake for most people, and that reduced intake is where most of the weight change comes from.
Blood sugar effects build over several weeks. Weight loss typically becomes noticeable after one to two months at a stable dose, and results vary widely between individuals. Stopping the medication usually leads to some weight regain.
Dose increases are deliberately slow because digestive side effects are strongest right after each step up.
Tirzepatide Shot Dosage and Schedule
Mounjaro and Zepbound use the same escalation schedule. Each dose is injected once weekly, on the same day each week, at any time of day with or without food.
| Step | Weekly dose | Typical duration | Notes |
|---|---|---|---|
| 1 | 2.5 mg | 4 weeks | Starting dose, not intended for blood sugar control |
| 2 | 5 mg | 4 weeks | First maintenance dose |
| 3 | 7.5 mg | 4 weeks | Optional step |
| 4 | 10 mg | 4 weeks | Optional step |
| 5 | 12.5 mg | 4 weeks | Optional step |
| 6 | 15 mg | Ongoing | Maximum approved weekly dose |
Your prescriber may hold you at a dose longer or move more quickly, depending on side effects and results. If you miss a dose, the manufacturer advises taking it within four days if possible; otherwise skip that dose and resume your normal weekly schedule. Never take two doses within three days of each other.
Injection sites include the abdomen, the front of the thigh, and the back of the upper arm. Rotate the site each week, using the same general body area but a different spot. Use a new needle or pen each time, and never share injection devices with another person. Do not inject into muscle or into skin that is bruised, tender, or scarred.
Tirzepatide Shot Side Effects and Safety
Most side effects are digestive and tend to ease after a few weeks at a given dose:
- Nausea, vomiting, diarrhea, or constipation
- Reduced appetite and early fullness
- Injection-site redness, itching, or mild pain
- Fatigue, headache, or acid reflux
Tirzepatide carries a boxed warning for thyroid C-cell tumors seen in rodent studies. It is contraindicated in people with a personal or family history of medullary thyroid cancer or MEN2.
Other reported risks include pancreatitis, gallbladder disease, kidney injury from dehydration, and low blood sugar, especially when tirzepatide is combined with insulin or sulfonylureas. Tirzepatide is not recommended during pregnancy and is generally stopped at least two months before a planned pregnancy. Talk with a licensed healthcare professional before starting, stopping, or combining tirzepatide with any other drug or peptide.
Brand-Name vs. Compounded Tirzepatide Shots
Both products contain the same active molecule, but they are not interchangeable in terms of regulation, testing, or cost. Compounded tirzepatide is not FDA-approved and does not carry the same manufacturing guarantees as Mounjaro or Zepbound.
| Feature | Brand (Mounjaro/Zepbound) | Compounded tirzepatide |
|---|---|---|
| FDA approval | Yes | No |
| Supply form | Single-dose pen or single-dose vial | Multi-dose vial, often a lyophilized powder |
| Oversight | FDA-regulated manufacturing | State pharmacy board; varies by pharmacy |
| Typical monthly cost | Roughly $300–$1,100 | Roughly $150–$400 |
| Insurance coverage | Often covered with prior authorization | Generally not covered |
Compounded vials often arrive as powder that must be mixed before use. People searching for how much bac water to reconstitute 20mg tirzepatide are usually trying to match a label concentration to a prescribed dose, and an error in that math can cause a serious overdose. A clinician or pharmacist should verify every reconstitution calculation.
Insurance coverage varies by plan. Savings cards, direct-to-consumer pharmacy programs, and prior authorizations can all change your out-of-pocket number.
Tirzepatide Shots vs. Other Options and Add-Ons
Several injectable options compete with tirzepatide, and the best choice depends on your goals, side-effect tolerance, and insurance coverage.
- Semaglutide (Ozempic, Wegovy) targets GLP-1 only and has a longer track record on the market.
- Retatrutide adds a glucagon component and remains investigational in the United States.
- Cagrilintide is an amylin analog studied mostly in combination with other agents, so any cagrilintide vs tirzepatide comparison is still a research question rather than an approved clinical choice.
Some people also ask about pairing tirzepatide with other peptides. There is no strong human evidence that aod 9604 with tirzepatide improves weight loss, and stacking products adds unknown risk. A similar caution applies to lipo c with b12 with tirzepatide — lipotropic injections are not FDA-approved for weight loss, and adding them raises the chance of interactions without proven benefit.
Anyone considering a tirzepatide shot should review their full medication list, including supplements and peptides, with a healthcare professional first. Clear medical supervision is the single biggest factor in using these injections safely.
Frequently Asked Questions
How much do tirzepatide shots cost without insurance?
Cash prices vary widely. Brand-name Mounjaro and Zepbound often run roughly $300 to $1,100 per month depending on dose and pharmacy program, while compounded vials typically fall between $150 and $400 per month. Savings cards, direct-to-consumer pharmacy options, and prior authorizations can lower the brand-name price significantly.
How long do tirzepatide shots take to work?
Appetite changes are often noticeable within the first one to two weeks, but meaningful weight loss usually appears after one to two months at a stable maintenance dose. Blood sugar improvements build gradually over several weeks. Full results depend on dose, duration of treatment, and lifestyle changes.
Can you take tirzepatide shots if you do not have diabetes?
Yes. Zepbound is FDA-approved for chronic weight management in adults with obesity, or with overweight plus at least one weight-related condition such as high blood pressure or high cholesterol. Mounjaro is approved for type 2 diabetes and is sometimes prescribed off-label for weight loss. A prescriber determines eligibility based on BMI, medical history, and other risk factors.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.